|
|
|
|
| Symbol(s): |
MED |
| Date: |
7-Feb-10 |
| Contributor: |
PriceTarget Research, Inc. |
| Title: |
Medifast has a current Overall Rating of A (Highest Rating). |
| Document Size: |
7 pages |
| Price: |
$25 |
| Document Type: |
Adobe Acrobat Reader®
Download free Adobe Acrobat Reader® |
|
| Research Reports Premium Services |
| ·
|
Get the full report for $25. |
| ·
|
You will have access to this report for 24 hours. |
|
|
|
|
|
| Medifast has a current Overall Rating of A (Highest Rating). Power Rating (99) is very high; appreciation potential (68) is high. Relative to the S&P 500 Composite, Medifast Inc has significant Growth characteristics -- its appeal is likely to be to Capital Gain-oriented investors. MED is of high investment quality. Medifast's current technical position is mixed. Medifast's Power Rating is 99. The recent trend in MED's earnings estimates has been extremely favorable. Medifast's...
| | |
|
|
